Pratt D, Sahm F, Aldape K (2021) DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology. Neuro Oncol 23:S16–S29. https://doi.org/10.1093/neuonc/noab143

Article  PubMed  PubMed Central  Google Scholar 

Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I et al (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164:1060–1072. https://doi.org/10.1016/j.cell.2016.01.015

Article  CAS  PubMed  PubMed Central  Google Scholar 

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lebrun L, Allard-Demoustiez S, Gilis N, Van Campenhout C, Rodesch M, Roman C, Calo P, Lolli V, David P, Fricx C et al (2023) Clinicopathological and molecular characterization of a case classified by DNA-methylation profiling as “CNS embryonal tumor with BRD4-LEUTX fusion.” Acta Neuropathol Commun 11:46. https://doi.org/10.1186/s40478-023-01549-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wong M, Mayoh C, Lau LMS, Khuong-Quang DA, Pinese M, Kumar A, Barahona P, Wilkie EE, Sullivan P, Bowen-James R et al (2020) Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer. Nat Med 26:1742–1753. https://doi.org/10.1038/s41591-020-1072-4

Article  CAS  PubMed  Google Scholar 

Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474. https://doi.org/10.1038/nature26000

Article  CAS  PubMed  PubMed Central  Google Scholar 

Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, Grobner S, Segura-Wang M, Zichner T, Rudneva VA et al (2017) The whole-genome landscape of medulloblastoma subtypes. Nature 547:311–317. https://doi.org/10.1038/nature22973

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tauziede-Espariat A, Figarella-Branger D, Metais A, Uro-Coste E, Maurage CA, Lhermitte B, Aline-Fardin A, Hasty L, Vasiljevic A, Chiforeanu D et al (2023) CNS neuroblastoma, FOXR2-activated and its mimics: a relevant panel approach for work-up and accurate diagnosis of this rare neoplasm. Acta Neuropathol Commun 11:43. https://doi.org/10.1186/s40478-023-01536-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15–21. https://doi.org/10.1093/bioinformatics/bts635

Article  CAS  PubMed  Google Scholar 

Uhrig S, Ellermann J, Walther T, Burkhardt P, Frohlich M, Hutter B, Toprak UH, Neumann O, Stenzinger A, Scholl C et al (2021) Accurate and efficient detection of gene fusions from RNA sequencing data. Genome Res 31:448–460. https://doi.org/10.1101/gr.257246.119

Article  PubMed  PubMed Central  Google Scholar 

Robinson JT, Thorvaldsdottir H, Wenger AM, Zehir A, Mesirov JP (2017) Variant review with the integrative genomics viewer. Cancer Res 77:e31–e34. https://doi.org/10.1158/0008-5472.CAN-17-0337

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Z, Abdullaev Z, Pratt D, Chung HJ, Skarshaug S, Zgonc V, Perry C, Pack S, Saidkhodjaeva L, Nagaraj S et al (2022) Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics. Neuro Oncol 24:571–581. https://doi.org/10.1093/neuonc/noab227

Article  CAS  PubMed  Google Scholar 

Chakravarthy A, Furness A, Joshi K, Ghorani E, Ford K, Ward MJ, King EV, Lechner M, Marafioti T, Quezada SA et al (2018) Pan-cancer deconvolution of tumour composition using DNA methylation. Nat Commun 9:3220. https://doi.org/10.1038/s41467-018-05570-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johann PD, Jager N, Pfister SM, Sill M (2019) RF_Purify: a novel tool for comprehensive analysis of tumor-purity in methylation array data based on random forest regression. BMC Bioinform 20:428. https://doi.org/10.1186/s12859-019-3014-z

Article  CAS  Google Scholar 

Habiba U, Sugino H, Yordanova R, Ise K, Tanei ZI, Ishida Y, Tanikawa S, Terasaka S, Sato KI, Kamoshima Y et al (2021) Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study. Acta Neuropathol Commun 9:95. https://doi.org/10.1186/s40478-021-01194-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barresi S, Giovannoni I, Rossi S, Stracuzzi A, Quacquarini D, Cafferata B, Piscitelli D, De Leonardis F, Marzullo A, Alaggio R (2021) A novel BRD4-LEUTX fusion in a pediatric sarcoma with epithelioid morphology and diffuse S100 expression. Genes Chromosom Cancer 60:647–652. https://doi.org/10.1002/gcc.22974

Article  CAS  PubMed  Google Scholar 

Wang R, You J (2015) Mechanistic analysis of the role of bromodomain-containing protein 4 (BRD4) in BRD4-NUT oncoprotein-induced transcriptional activation. J Biol Chem 290:2744–2758. https://doi.org/10.1074/jbc.M114.600759

Article  CAS  PubMed  Google Scholar 

Thompson-Wicking K, Francis RW, Stirnweiss A, Ferrari E, Welch MD, Baker E, Murch AR, Gout AM, Carter KW, Charles AK et al (2013) Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma. Oncogene 32:4664–4674. https://doi.org/10.1038/onc.2012.487

Article  CAS  PubMed  Google Scholar 

Donati B, Lorenzini E, Ciarrocchi A (2018) BRD4 and Cancer: going beyond transcriptional regulation. Mol Cancer 17:164. https://doi.org/10.1186/s12943-018-0915-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song K, Huang Y, Xia CD, Zhu HQ, Wang J (2022) A case of CIC-rearranged sarcoma with CIC-LEUTX gene fusion in spinal cord. Neuropathology 42:555–562. https://doi.org/10.1111/neup.12850

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brcic I, Brodowicz T, Cerroni L, Kashofer K, Serbanescu GL, Kasseroler MT, Amann G, Scheipl S, Szkandera J, Leithner A, Liegl-Atzwanger B (2020) Undifferentiated round cell sarcomas with CIC-DUX4 gene fusion: expanding the clinical spectrum. Pathology 52:236–242. https://doi.org/10.1016/j.pathol.2019.09.015

Article  CAS  PubMed  Google Scholar 

Sievers P, Sill M, Schrimpf D, Abdullaev Z, Donson AM, Lake JA, Friedel D, Scheie D, Tynninen O, Rauramaa T et al (2023) Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature. NPJ Precis Oncol 7:30. https://doi.org/10.1038/s41698-023-00372-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang S, Roeder RG (2020) The long and the short of BRD4: two tales in breast cancer. Mol Cell 78:993–995. https://doi.org/10.1016/j.molcel.2020.05.033

Article  CAS  PubMed  Google Scholar 

Wu SY, Chiang CM (2007) The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J Biol Chem 282:13141–13145. https://doi.org/10.1074/jbc.R700001200

Article  CAS  PubMed  Google Scholar 

Alsarraj J, Walker RC, Webster JD, Geiger TR, Crawford NP, Simpson RM, Ozato K, Hunter KW (2011) Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion. Cancer Res 71:3121–3131. https://doi.org/10.1158/0008-5472.CAN-10-4417

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duan Y, Guan Y, Qin W, Zhai X, Yu B, Liu H (2018) Targeting Brd4 for cancer therapy: inhibitors and degraders. Medchemcomm 9:1779–1802. https://doi.org/10.1039/c8md00198g

Article  CAS  PubMed  PubMed Central  Google Scholar 

Decock A, Creytens D, Lefever S, Van der Meulen J, Anckaert J, De Ganck A, Deleu J, De Wilde B, Fierro C, Kuersten S et al (2022) mRNA Capture Sequencing and RT-qPCR for the detection of pathognomonic, novel, and secondary fusion transcripts in FFPE tissue: a sarcoma showcase. Int J Mol Sci. https://doi.org/10.3390/ijms231911007

Article  PubMed  PubMed Central  Google Scholar 

Keck MK, Sill M, Wittmann A, Joshi P, Stichel D, Beck P, Okonechnikow K, Sievers P, Wefers AK, Roncaroli F et al (2023) Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. Acta Neuropathol 145:49–69. https://doi.org/10.1007/s00401-022-02516-2

Article  CAS  PubMed  Google Scholar 

Wiles ET, Selker EU (2017) H3K27 methylation: a promiscuous repressive chromatin mark. Curr Opin Genet Dev 43:31–37. https://doi.org/10.1016/j.gde.2016.11.001

Article  CAS  PubMed  Google Scholar